Back to Search
BETH EISENBERG, PHD
PHD
Clinical Psychologist
NPI: 1760261762Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
PSY25947(CA)
Research & Publications (20)
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
PMID 18942073·J Surg Oncol·2009
3-trial
Combined-modality strategy for gastrointestinal stromal tumors.
PMID 17178293·Semin Oncol·2006
6-review
Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials.
PMID 17101065·Clin Colorectal Cancer·2006
6-review
Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.
PMID 15123459·Ann Surg Oncol·2004
6-review
Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors.
PMID 14682111·Oncology (Williston Park)·2003
6-review
Pharmacotherapy of gastrointestinal stromal tumours.
PMID 12783584·Expert Opin Pharmacother·2003
6-review
Ionic selectivity in L-type calcium channels by electrostatics and hard-core repulsion.
PMID 19398776·J Gen Physiol·2009
7-preclinical
High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.
PMID 19585585·Genes Chromosomes Cancer·2009
8-other
Targeted therapies: GIST adjuvant therapy-some answers and more questions.
PMID 19644534·Nat Rev Clin Oncol·2009
8-other
Ions and inhibitors in the binding site of HIV protease: comparison of Monte Carlo simulations and the linearized Poisson-Boltzmann theory.
PMID 19217848·Biophys J·2009
4-observational
Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.
PMID 19116881·Nutr Cancer·2009
8-other
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.
PMID 19671739·Mol Cancer Ther·2009
3-trial
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.
PMID 18235121·J Clin Oncol·2008
3-trial
The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.
PMID 18259941·Cancer Invest·2008
8-other
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.
PMID 18550829·Proc Natl Acad Sci U S A·2008
8-other
The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.
PMID 18818517·Cell Cycle·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 23043 BURTON ST
WEST HILLS, CA 91304 - Phone
- (818) 704-1007
Quick Facts
- NPI
- 1760261762
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile